GGrantIndex
← Leaderboards

Daniel J Sargent

Mayo Clinic Coll Of Medicine, Rochester

$25,249,854
Attributed
$25,249,854
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $7.8M · FY200518
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$38,692,252 · 8

By mechanism

U10$29,615,175 · 2
P30$8,515,318 · 4
R01$561,759 · 1
P50$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Mayo Clinic Coll Of Medicine, Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsData ManagementResearch PersonnelCollaborationsFundingFacultyBasic ScienceMalignant NeoplasmsTranslational ResearchCancer PatientMeasurementGrantPublicationsMayo Clinic Cancer CenterObservational StudyQuality Of LifePopulation SciencesPsychosocialBiostatistics Shared ResourceAreaCancer Center Support GrantPilot ProjectsFamily CaregiverPeer Review

Grant awards (28)

Biostatistics Shared Resource$614,591
P30 · FY2018 · CA · contact PI
Biostatistics Shared Resource$7,439
P30 · FY2018 · CA · contact PI
Biostatistics Shared Resource$6,547
P30 · FY2018 · CA · contact PI
Biostatistics Shared Resource$2,609
P30 · FY2018 · CA · contact PI
Biostatistics Shared Resource$620,995
P30 · FY2017 · CA · contact PI
Biostatistics Shared Resource$614,588
P30 · FY2016 · CA · contact PI
Statistics and Data Center for the Alliance for Clinical Trials in Oncology$6,892,682
U10 · FY2015 · CA · contact PI
Biostatistics Shared Resource$612,579
P30 · FY2015 · CA · contact PI
Methodology for development, validation, and use of novel endpoints in oncology$296,091
R01 · FY2015 · CA · contact PI
Statistics and Data Center for the Alliance for Clinical Trials in Oncology$6,549,716
U10 · FY2014 · CA · contact PI
Biostatistics Shared Resource$576,349
P30 · FY2014 · CA · contact PI
Methodology for development, validation, and use of novel endpoints in oncology$265,668
R01 · FY2014 · CA · contact PI
Cancer and Leukemia Group B Statistical Center$4,309,956
U10 · FY2013 · CA · contact PI
Biostatics$510,880
P30 · FY2013 · CA · contact PI
Cancer and Leukemia Group B Statistical Center$4,701,770
U10 · FY2012 · CA · contact PI
Biostatics$429,436
P30 · FY2012 · CA · contact PI
Cancer and Leukemia Group B Statistical Center$4,682,808
U10 · FY2011 · CA · contact PI
Biostatics$531,906
P30 · FY2011 · CA · contact PI
Cancer and Leukemia Group B Statistical Center$2,478,243
U10 · FY2010 · CA · contact PI
Biostatics$564,761
P30 · FY2010 · CA · contact PI
Biostatics$569,370
P30 · FY2009 · CA · contact PI
CORE--BIOSTATISTICS$816,108
P30 · FY2008 · CA · contact PI
CORE--BIOSTATISTICS$804,754
P30 · FY2007 · CA · contact PI
CORE--BIOSTATISTICS$434,913
P30 · FY2006 · CA · contact PI
CORE--BIOSTATISTICS$422,245
P30 · FY2005 · CA
CORE--BIOSTATISTICS$375,248
P30 · FY2004 · CA
CORE--BIOSTATISTICS$0
P50 · FY2002 · CA
CORE--BIOSTATISTICS$0
P50 · FY2001 · CA